Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Quark Biotech enters research agreement with Sankyo for diabetes drug

Feb. 19, 1999

Ariad achieves second milestone in HMR collaboration

Feb. 19, 1999

Statins may be drugs of choice for adolescents with HeFH

Feb. 18, 1999

First orally active, nonsteroidal androgen receptor agonist discovered at Ligand

Feb. 18, 1999

Dainippon will initiate overseas trials of beta3 agonist

Feb. 18, 1999

Yamanouchi, Ono establish codevelopment and marketing agreement for bisphosphonate

Feb. 18, 1999

Preliminary results of testosterone replacement gel reported

Feb. 18, 1999

Sildenafil safe and effective in the treatment of ED in diabetic men

Feb. 17, 1999

ZD-4522 enters accelerated phase III trial program

Feb. 16, 1999

Cellegy initiates clinical trial with transdermal testosterone gel

Feb. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...